Clinical Trials Browser

Phase 2 × Melanoma × lorukafusp alfa × Clear all

NCT00590824 2019-11-21

Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma

Phase 2 Completed

23 enrolled 22 charts

Melanoma

NCT00109863 2019-11-19

Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma

Phase 2 Completed

Melanoma